Odisha's Covid-19 tally crosses 300,000-mark, 14 deaths push toll to 1,410

Odisha's Covid-19 tally crossed the 300,000-mark as 1,372 more people tested positive for the infection, while 17 fresh fatalities pushed the state's coronavirus death toll to 1,410

Coronavirus, covid, tests
Healthcare worker wearing Personal Protective Equipment screens a person in the wake of coronavirus pandemic
Press Trust of India Bhubaneswar
2 min read Last Updated : Nov 07 2020 | 1:54 PM IST

Odisha's COVID-19 tally crossed the three lakh-mark on Saturday as 1,372 more people tested positive for the infection, while 17 fresh fatalities pushed the state's coronavirus death toll to 1,410, a health department official said.

The fresh infections reported from all the 30 districts have taken the state's caseload to 3,00,140, he said.

Of the 1,372 new cases, 796 were detected in quarantine centres, and the rest found during contact tracing.

Khurda district, of which the state capital Bhubaneswar is a part, reported the maximum number of fresh cases at 145, followed by Cuttack at 121 and Nuapada at 108, the official said.

Taking to Twitter, the Health and Family Welfare Department said, "Regret to inform the demise of seventeen #COVID19 positive patients while under treatment in hospitals."

Three fresh fatalities were reported from Khurda and two each from Cuttack, Mayurbhanj, Sambalpur and Bargarh.

One each died in the districts of Puri, Balasore, Koraput, Kalahandi, Kendrapara and Bhadrak.

Khurda has accounted for the highest number of fatalities so far at 245, followed by Ganjam at 231 and Cuttack at 118. Fifty-three COVID-19 patients have died due to pre-existing ailments.

Odisha currently has 13,503 active patients, while 2,85,174 people have recovered from the disease.

The positivity rate in the state stands at 6.14 per cent, the official said.

Over 48.88 lakh sample tests have been conducted for COVID-19 so far, including 50,385 on Friday, he added.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOdisha Naveen PatnaikCoronavirus TestsCoronavirus VaccineIndia healthcareIndian healthcare systemHealth crisisHealth Ministry

First Published: Nov 07 2020 | 1:43 PM IST

Next Story